These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29773835)

  • 21. Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis.
    Koster G; Wetterslev J; Gluud C; Zijlstra JG; Scheeren TW; van der Horst IC; Keus F
    Intensive Care Med; 2015 Feb; 41(2):203-21. PubMed ID: 25518953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of levosimendan for perioperative cardiovascular dysfunction in patients receiving cardiac surgery: a meta-analysis with trial sequential analysis.
    Lee CT; Lin YC; Yeh YC; Chen TL; Chen CY
    Intensive Care Med; 2017 Dec; 43(12):1929-1930. PubMed ID: 28884347
    [No Abstract]   [Full Text] [Related]  

  • 23. Perioperative levosimendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery: a meta-analysis.
    Niu ZZ; Wu SM; Sun WY; Hou WM; Chi YF
    J Cardiovasc Pharmacol; 2014 Feb; 63(2):107-12. PubMed ID: 24126568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levosimendan for Prevention of Acute Kidney Injury After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials.
    Zhou C; Gong J; Chen D; Wang W; Liu M; Liu B
    Am J Kidney Dis; 2016 Mar; 67(3):408-16. PubMed ID: 26518388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
    Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
    Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.
    Mehta RH; Van Diepen S; Meza J; Bokesch P; Leimberger JD; Tourt-Uhlig S; Swartz M; Parrotta J; Jankowich R; Hay D; Harrison RW; Fremes S; Goodman SG; Luber J; Toller W; Heringlake M; Anstrom KJ; Levy JH; Harrington RA; Alexander JH;
    Am Heart J; 2016 Dec; 182():62-71. PubMed ID: 27914501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials.
    Chang W; Xie JF; Xu JY; Yang Y
    BMJ Open; 2018 Mar; 8(3):e019338. PubMed ID: 29602841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis.
    Sanfilippo F; Knight JB; Scolletta S; Santonocito C; Pastore F; Lorini FL; Tritapepe L; Morelli A; Arcadipane A
    Crit Care; 2017 Oct; 21(1):252. PubMed ID: 29047417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levosimendan Following Cardiac Surgery.
    Conte SM; Florisson DS; De Bono JA; Davies RA; Newcomb AE
    Heart Lung Circ; 2019 Mar; 28(3):e19-e20. PubMed ID: 29581038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levosimendan for Perioperative Cardioprotection: Myth or Reality?
    Santillo E; Migale M; Massini C; Incalzi RA
    Curr Cardiol Rev; 2018; 14(3):142-152. PubMed ID: 29564979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Perioperative Levosimendan Administration on Risk of Bleeding After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials.
    Yan SB; Wang XY; Shang GK; Wang ZH; Deng QM; Song JW; Sai WW; Song M; Zhong M; Zhang W
    Am J Cardiovasc Drugs; 2020 Apr; 20(2):149-160. PubMed ID: 31523760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Levosimendan on Renal Outcome in Cardiac Surgery Patients With Chronic Kidney Disease and Perioperative Cardiovascular Dysfunction: A Substudy of a Multicenter Randomized Trial.
    Zangrillo A; Alvaro G; Belletti A; Pisano A; Brazzi L; Calabrò MG; Guarracino F; Bove T; Grigoryev EV; Monaco F; Boboshko VA; Likhvantsev VV; Scandroglio AM; Paternoster G; Lembo R; Frassoni S; Comis M; Pasyuga VV; Navalesi P; Lomivorotov VV;
    J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2152-2159. PubMed ID: 29580796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of levosimendan on clinical outcomes in adult patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials.
    Zhou X; Hu C; Xu Z; Liu P; Zhang Y; Sun L; Wang Y; Gao X
    Interact Cardiovasc Thorac Surg; 2018 Jun; 26(6):1016-1026. PubMed ID: 29415177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension.
    Schroeder L; Holcher S; Leyens J; Geipel A; Strizek B; Dresbach T; Mueller A; Kipfmueller F
    Eur J Pediatr; 2023 Jul; 182(7):3165-3174. PubMed ID: 37100959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-Analysis of the Efficacy of Levosimendan in the Treatment of Severe Sepsis Complicated with Septic Cardiomyopathy.
    Guan Q; Zhang C; Li B; Huang D; Li A; Qin J; Zhang X
    Heart Surg Forum; 2023 Oct; 26(5):E609-E620. PubMed ID: 37920078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early levosimendan administration is associated with decreased mortality after cardiac surgery.
    Treskatsch S; Balzer F; Geyer T; Spies CD; Kastrup M; Grubitzsch H; Wernecke KD; Erb JM; Braun JP; Sander M
    J Crit Care; 2015 Aug; 30(4):859.e1-6. PubMed ID: 25837801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levosimendan Treatment for Heart Failure: A Systematic Review and Meta-Analysis.
    Gong B; Li Z; Yat Wong PC
    J Cardiothorac Vasc Anesth; 2015 Dec; 29(6):1415-25. PubMed ID: 26275522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts.
    Behrends M; Peters J
    Intensive Care Med; 2003 Oct; 29(10):1802-7. PubMed ID: 12879240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levosimendan for Hemodynamic Support after Cardiac Surgery.
    Landoni G; Lomivorotov VV; Alvaro G; Lobreglio R; Pisano A; Guarracino F; Calabrò MG; Grigoryev EV; Likhvantsev VV; Salgado-Filho MF; Bianchi A; Pasyuga VV; Baiocchi M; Pappalardo F; Monaco F; Boboshko VA; Abubakirov MN; Amantea B; Lembo R; Brazzi L; Verniero L; Bertini P; Scandroglio AM; Bove T; Belletti A; Michienzi MG; Shukevich DL; Zabelina TS; Bellomo R; Zangrillo A;
    N Engl J Med; 2017 May; 376(21):2021-2031. PubMed ID: 28320259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery.
    Erb J; Beutlhauser T; Feldheiser A; Schuster B; Treskatsch S; Grubitzsch H; Spies C
    J Int Med Res; 2014 Jun; 42(3):750-64. PubMed ID: 24781725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.